Login / Signup

Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation.

Alberto BenazzoAra ChoAnna NechayStefan SchwarzFlorian FrommletThomas WekerleKonrad HoetzeneckerPeter Jaksch
Published in: Trials (2021)
EUDRACT Nr 2018-001680-24. Registered on 15 May 2018.
Keyphrases
  • low dose
  • high dose
  • study protocol
  • clinical trial
  • phase iii
  • extracorporeal membrane oxygenation
  • phase ii
  • open label
  • bone marrow
  • smoking cessation